ADVFN Logo

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Tendenze

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

AZN

Astrazeneca (AZN)

Astrazeneca Plc
Da:
Ordina per:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:AZN
DataOraFonteTitoloSimboloCompagnia
07/12/202313:49Dow Jones NewsMerck Scraps Phase 3 Keytruda-Lynparza Lung Cancer StudyLSE:AZNAstrazeneca Plc
04/12/202316:41Dow Jones NewsAbsci Shares Rise 27% After Announcing Collaboration With AstraZenecaLSE:AZNAstrazeneca Plc
01/12/202316:05UK Regulatory (RNS & others)AstraZeneca PLC Block listing Interim ReviewLSE:AZNAstrazeneca Plc
01/12/202316:00UK Regulatory (RNS & others)AstraZeneca PLC Total Voting RightsLSE:AZNAstrazeneca Plc
01/12/202309:33Alliance NewsAlliance NewsAstraZeneca discontinues two phase III evidence trials for LokelmaLSE:AZNAstrazeneca Plc
01/12/202308:00UK Regulatory (RNS & others)AstraZeneca PLC Discontinuation of two CRYSTALIZE evidence trialsLSE:AZNAstrazeneca Plc
23/11/202319:41Alliance NewsAlliance NewsIN BRIEF: AstraZeneca Chair Demare buys shares for over GBP200,000LSE:AZNAstrazeneca Plc
23/11/202316:00UK Regulatory (RNS & others)AstraZeneca PLC Director/PDMR ShareholdingLSE:AZNAstrazeneca Plc
20/11/202311:49Alliance NewsAlliance NewsAstraZeneca launches new life sciences tech innovation firm EvinovaLSE:AZNAstrazeneca Plc
20/11/202309:41Dow Jones NewsAstraZeneca Launches Health-Tech Business Evinova -- UpdateLSE:AZNAstrazeneca Plc
20/11/202309:02Dow Jones NewsAstraZeneca Launches Health-Tech Business Evinova to Support Clinical StudiesLSE:AZNAstrazeneca Plc
17/11/202309:31Alliance NewsAlliance NewsTOP NEWS: US approves AstraZeneca's Truqap for form of breast cancerLSE:AZNAstrazeneca Plc
17/11/202308:00UK Regulatory (RNS & others)AstraZeneca PLC Truqap approved in US for HR+ breast cancerLSE:AZNAstrazeneca Plc
14/11/202311:51Alliance NewsAlliance NewsTOP NEWS: AstraZeneca Imfinzi fails to meet endpoint in cancer trialLSE:AZNAstrazeneca Plc
14/11/202308:05UK Regulatory (RNS & others)AstraZeneca PLC Update on PACIFIC-2 Phase III trial for ImfinziLSE:AZNAstrazeneca Plc
09/11/202316:00UK Regulatory (RNS & others)AstraZeneca PLC Director DeclarationLSE:AZNAstrazeneca Plc
09/11/202313:03Dow Jones NewsTrending: AstraZeneca Hikes Forecasts and Makes a $2 Billion Licensing DealLSE:AZNAstrazeneca Plc
09/11/202310:23Alliance NewsAlliance NewsTOP NEWS: AstraZeneca ups guidance; inks licence deal for obesity drugLSE:AZNAstrazeneca Plc
09/11/202309:57Dow Jones NewsAstraZeneca Shares Rise After Guidance IncreaseLSE:AZNAstrazeneca Plc
09/11/202309:16Dow Jones NewsAstraZeneca Agrees on Licensing Deal for Obesity TreatmentLSE:AZNAstrazeneca Plc
09/11/202309:03Dow Jones NewsAstraZeneca Raises Core EPS Guidance Despite Profit Miss -- UpdateLSE:AZNAstrazeneca Plc
09/11/202308:50Dow Jones NewsAstraZeneca Raises Core EPS Guidance Despite Profit MissLSE:AZNAstrazeneca Plc
09/11/202308:10UK Regulatory (RNS & others)AstraZeneca PLC Imfinzi combination improves PFS in liver cancerLSE:AZNAstrazeneca Plc
09/11/202308:05UK Regulatory (RNS & others)AstraZeneca PLC Agreement with Eccogene for clinical stage GLP-1RALSE:AZNAstrazeneca Plc
09/11/202308:00UK Regulatory (RNS & others)AstraZeneca PLC 9M and Q3 2023 resultsLSE:AZNAstrazeneca Plc
03/11/202318:06Alliance NewsAlliance NewsAstraZeneca plans next phase of trial on kidney drug combination dataLSE:AZNAstrazeneca Plc
03/11/202312:34Alliance NewsAlliance NewsAstraZeneca's Lokelma lets kidney disease patients maintain therapyLSE:AZNAstrazeneca Plc
01/11/202312:52Dow Jones NewsCellectis Shares Soar Premarket on AstraZeneca DealLSE:AZNAstrazeneca Plc
01/11/202309:59Alliance NewsAlliance NewsAstraZeneca launches collaboration and investment deal with CellectisLSE:AZNAstrazeneca Plc
01/11/202309:17Dow Jones NewsAstraZeneca to Invest $245 Million in Deal With CellectisLSE:AZNAstrazeneca Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:AZN
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

Support: +39 02 3045 3014 | support@advfn.it